ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,970, issued on Aug. 26, was assigned to AltaThera Pharmaceuticals LLC (Chicago).
"Anti-arrhythmic compositions and methods" was invented by Brandon Ira Kashfian (Chicago) and Jodi Devlin (Chicago).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of administering an anti-arrhythmic, such as dofetilide, to a patient in an amount effective for treating a cardiovascular condition are described. The drug can be administered intravenously for at least one hour. A loading dose of 0.1 to 12 Mug/kg bodyweight over a duration of up to 60 minutes can be administered and/or a maintenance dose of 0.1 to 10 Mug/kg/hr can be administered intravenously over a ...